At RIV Capital, our objective is making investments that generate returns in the form of dividends, capital appreciation, interest, rent, and royalties. As a result, we currently do not report financial
metrics that are typical of Canadian LPs or U.S. MSOs, such as revenue or cost of goods sold. Instead, you will see items on our financial statements such as interest income, fair value changes, and others.
To help better understand how we account for our investments, we created a helpful infographic that provides clarity in how we classify our investments and how that translates in our financials.
We invite you to learn more about RIV Capital by visiting the investor section of our website.
RIV Capital’s investees, and the related financial instruments we used to invest in these investees, generally fall into one of three buckets for accounting purposes.
The first bucket is equity method investees. Equity method investees generally have the following characteristics:
Our investments in equity method investees are initially recorded at cost, and the related financial statement balance is adjusted up or down each period based on our proportionate share of the income or loss generated by the investee.
As such, the values on our statement of financial position for equity method investees do not necessarily reflect how a market participant may fair value those assets. Our equity method investees include some of our larger investments, such as our investment in PharmHouse.
The second bucket is financial assets. Financial asset investments generally have one of the following characteristics:
Our investments in financial assets are generally recorded at fair value each quarter. Changes in fair value from quarter to quarter will either flow through “profit or loss” or “P&L” or show up in what is called “other
comprehensive income or loss” or “OCI”.
Those investments that flow through P&L are generally our yield-oriented investments – such as royalty instruments, debentures, or preferred shares with cumulative dividends – or are those financial assets that are required under the accounting
standards to flow through P&L, such as derivative financial instruments. The instruments that flow through OCI are generally the common or preferred equity positions that are intended at inception to be long-term and strategic in nature. All of
our equity investments in publicly traded companies would fall into this Fair Value Through through Other Comprehensive Income (FVTOCI) sub-category.
The third and final bucket is a generic category, which includes instruments that don’t fall into the other two buckets, such as our shareholder loan to PharmHouse.
We may hold multiple financial instruments for our investees. For example, we hold convertible debentures and warrants in Greenhouse Juice.
In total, we hold 30 different financial instruments across our 13 investees. Each individual instrument has its own unique accounting treatment. When you layer these 30 different financial instruments on top of 13 investees, the result
is a somewhat complex set of financial statements. We strive to reduce that complexity by ensuring a robust level of disclosure in our financial statements and MD&A.
Despite the challenges associated with this complexity, we believe that our ability to create multi-faceted investment structures differentiates us. We offer a compelling value proposition to visionary investors looking to
unlock the long-term value of the global cannabis industry. We are where the smart money goes.
Last updated: March 2, 2021.
This is not an offer to sell or a recommendation to trade in any securities. This information is provided as of the date hereof. This document contains data obtained from third parties that RIV Capital has not independently verified. This document also contains forward-looking information within the meaning of Canadian securities law, which is based on certain assumptions. While management believes these assumptions are reasonable based on information available as of the current date, they may prove to be incorrect. Many assumptions are based on factors outside of RIV Capital’s control and actual results may differ materially from current expectations. Forward-looking information involves risks, including, but not limited to, the risk factors set out in RIV Capital’s most recent Management’s Discussion and Analysis and Annual Information Form. You should not place undue reliance on forward-looking information. Except as required by applicable law, RIV Capital assumes no obligation to update or revise any forward-looking information to reflect new events or circumstances.
Please select how you would like to hear from RIV Capital:
We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.